DNTH Institutional Ownership & Shareholders

DIANTHUS THERAPEUTICS INC (DNTH) is currently held by 264 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $6.35B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Fmr Llc is currently the largest disclosed institutional shareholder of DNTH tracked by InsiderSet, reporting ownership valued at approximately $799.33M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $675.51M, representing an estimated loss of -15.49% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 51% of the total disclosed DNTH value among the investors covered in this analysis. Major shareholders include Fmr Llc, Blackrock, Inc., T. Rowe Price Investment Management, Inc., and several other long-term asset managers with concentrated positions in DIANTHUS THERAPEUTICS INC (DNTH).

This page ranks the largest institutional DNTH shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

264

Total Reported Value

$6.35B

Largest Holder

Fmr Llc

Largest Position

$799.33M

Insider Transactions (90d)

41

Latest Filing Quarter

Q2 2026

New Institutional Positions

77

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Fmr Llc0.03%8,199,893$799,325,570$675,507,185-$123,818,385-15.49%
Blackrock, Inc.0.01%4,123,822$401,990,169$339,720,456-$62,269,713-15.49%
T. Rowe Price Investment Management, Inc.0.25%3,888,456$379,047,000$320,331,005-$58,715,995-15.49%
Wellington Management Group Llp0.05%3,229,882$314,848,897$266,077,679-$48,771,218-15.49%
Fairmount Funds Management Llc16.35%2,537,191$247,325,379$209,013,795-$38,311,584-15.49%
Price T Rowe Associates Inc0.02%2,514,946$245,158,000$207,181,251-$37,976,749-15.49%
State Street Corp0.01%2,357,440$229,798,634$194,205,907-$35,592,727-15.49%
Vanguard Capital Management Llc0.00%2,159,568$210,514,689$177,905,212-$32,609,477-15.49%
Avidity Partners Management Lp32.85%2,104,184$205,115,856$173,342,678-$31,773,178-15.49%
Octagon Capital Advisors Lp16.48%1,841,667$179,525,699$151,716,527-$27,809,172-15.49%
Tcg Crossover Management, Llc3.93%1,676,624$163,437,308$138,120,285-$25,317,023-15.49%
Fred Alger Management, Llc0.42%1,302,493$126,967,018$107,299,373-$19,667,645-15.49%
Geode Capital Management, Llc0.01%1,258,502$122,696,604$103,675,395-$19,021,209-15.50%
Venrock Adviser, Llc3.49%1,180,000$115,026,400$97,208,400-$17,818,000-15.49%
Ubs Group Ag0.02%1,140,260$111,152,545$93,934,619-$17,217,926-15.49%
Deerfield Management Company, L.P.1.14%1,125,313$109,695,511$92,703,285-$16,992,226-15.49%
Jennison Associates Llc0.06%1,021,763$99,601,453$84,172,836-$15,428,617-15.49%
Polar Capital Holdings Plc0.28%1,018,726$99,305,410$83,922,648-$15,382,762-15.49%
Citadel Advisors Llc0.05%974,911$95,034,324$80,313,168-$14,721,156-15.49%
Baker Bros. Advisors Lp0.42%852,164$83,068,947$70,201,270-$12,867,677-15.49%
Logos Global Management Lp3.36%800,000$77,984,000$65,904,000-$12,080,000-15.49%
Cormorant Asset Management, Lp3.75%750,000$73,110,000$61,785,000-$11,325,000-15.49%
Alliancebernstein L.P.0.02%834,150$70,001,868$68,717,277-$1,284,591-1.84%
Assenagon Asset Management S.A.0.06%732,246$64,474,260$60,322,425-$4,151,835-6.44%
Braidwell Lp2.14%594,562$57,957,904$48,980,018-$8,977,886-15.49%
Vanguard Portfolio Management Llc0.00%570,115$55,574,810$46,966,074-$8,608,736-15.49%
Ameriprise Financial Inc0.01%531,999$51,859,546$43,826,078-$8,033,468-15.49%
Woodline Partners Lp0.15%500,548$48,793,419$41,235,144-$7,558,275-15.49%
Barclays Plc0.01%431,753$42,087,284$35,567,812-$6,519,472-15.49%
Lord, Abbett & Co. Llc0.12%422,185$41,155,000$34,779,600-$6,375,400-15.49%
Mpm Bioimpact Llc2.50%420,002$40,941,795$34,599,765-$6,342,030-15.49%
Northern Trust Corp0.00%411,791$40,141,386$33,923,343-$6,218,043-15.49%
Affinity Asset Advisors, Llc1.91%400,000$38,992,000$32,952,000-$6,040,000-15.49%
Silverarc Capital Management, Llc4.23%390,000$38,017,200$32,128,200-$5,889,000-15.49%
Goldman Sachs Group Inc0.00%382,161$37,253,054$31,482,423-$5,770,631-15.49%
Charles Schwab Investment Management Inc0.00%365,963$35,674,073$30,148,032-$5,526,041-15.49%
Bain Capital Life Sciences Investors, Llc2.10%362,470$35,333,576$29,860,279-$5,473,297-15.49%
Spruce Street Capital Lp6.79%354,816$34,587,464$29,229,742-$5,357,722-15.49%
Vivo Capital, Llc3.15%353,998$34,507,725$29,162,355-$5,345,370-15.49%
Dimensional Fund Advisors Lp0.01%321,503$31,334,301$26,485,417-$4,848,884-15.47%
Westfield Capital Management Co Lp0.10%314,914$30,697,817$25,942,615-$4,755,202-15.49%
Vanguard Fiduciary Trust Co0.01%302,482$29,485,945$24,918,467-$4,567,478-15.49%
Driehaus Capital Management Llc0.17%295,266$28,782,530$24,324,013-$4,458,517-15.49%
First Turn Management, Llc2.98%285,771$27,856,957$23,541,815-$4,315,142-15.49%
Catalio Capital Management, Lp4.76%653,572$26,933,702$53,841,261+$26,907,559+99.90%
Tang Capital Management Llc1.17%264,692$25,802,176$21,805,327-$3,996,849-15.49%
Artisan Partners Limited Partnership0.04%258,269$25,176,062$21,276,200-$3,899,862-15.49%
Bank Of America Corp0.00%256,833$25,036,081$21,157,903-$3,878,178-15.49%
Bank Of New York Mellon Corp0.00%256,393$24,993,153$21,121,655-$3,871,498-15.49%
Rtw Investments, Lp0.21%248,063$24,181,181$20,435,430-$3,745,751-15.49%
Showing 50 of 264

Frequently asked questions about DNTH

  • Who are the largest institutional holders of DNTH?

    The largest institutional holders of DNTH reported in the latest SEC Form 13F filings include Fmr Llc, Blackrock, Inc., T. Rowe Price Investment Management, Inc., Wellington Management Group Llp, and Fairmount Funds Management Llc. InsiderSet ranks institutional holders by their latest reported DNTH position.

  • What is DNTH institutional ownership?

    This page tracks DNTH positions reported by institutional investment managers through SEC Form 13F. DIANTHUS THERAPEUTICS INC (DNTH) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own DNTH?

    InsiderSet currently tracks 264 institutional managers reporting DNTH holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of DNTH shareholders.

  • How much DNTH stock do institutions own?

    Institutional investment managers disclosed approximately $6.35B in DNTH holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was DNTH institutional ownership last updated?

    The latest DNTH institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional DNTH holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its DNTH position after the reporting date.

  • Are institutions buying or selling DNTH?

    Institutional buying and selling can be analyzed by comparing DNTH positions across consecutive 13F reporting periods. InsiderSet's DNTH Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View DNTH ownership changes.

  • How has DNTH institutional ownership changed over time?

    InsiderSet tracks DNTH institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.